STATUS EPILEPTICUS: A Critical Care Masterclass | Scientific Webinar

Status epilepticus is a life-threatening neurological emergency that demands rapid diagnosis, timely intervention, and coordinated multidisciplinary management. This webinar will focus on the latest evidence, clinical protocols, diagnostic insights, and advanced treatment strategies essential for managing refractory and super-refractory status epilepticus in the critical care setting. Participants will gain a deeper understanding of pathophysiology, EEG-based assessment, sedation strategies, antiepileptic drug selection, airway and ventilatory management, and neurocritical care monitoring. Real-world case presentations will illustrate clinical reasoning, escalation pathways, and team-based decision-making to optimize patient outcomes.

Examiners: Dr. G. V. Subbaiah Chowdary, Dr. J. S. K. Chaitanya
Course Director: Dr. Venkat Raman Kola
Moderator: Dr. V. Ravi Sankar
Case Presentations: Dr. Komali, Dr. Ranga Bharadwaj
Organising Team: Dr. Kaladhar S, Dr. Madhusudan R. Jaju, Dr. Karthik Munta

Video Timelines:
00:00 – Introduction & examiners
01:39 – Patient history, vitals & exam summary
05:02 – Differential diagnosis & initial management
09:26 – ICU admission, airway & imaging/EEG
13:39 – Drug considerations in CKD & CSF analysis
19:42 – Further differential reasoning & key takeaways
21:22 – EEG findings; initial CSF normal, serial EEG improved
22:22 – Day 4: patient ventilated, dialysis done, MRA flakes; repeat CSF shows non-convulsive status
23:53 – Burst suppression protocol & refractory causes (autoimmune, drugs, dialysis)
28:36 – Day 5: GCS E3VT M5; PET suggests autoimmune encephalitis; CSF panel sent
32:31 – Anti-epileptics: levetiracetam preferred; phenytoin/phenobarbital precautions; alternative infusions (copopal, ketamine)
40:42 – Propofol caution; midazolam titration; breakthrough seizures dosing (midazolam & ketamine)
44:36 – Ketamine early use + other drugs; seizure control tips; propofol may mimic jerks
46:09 – Autoimmune management: steroids first-line, IVIG in dialysis; PET faster than CSF antibodies
51:27 – Refractory options: ketogenic diet, ECT, vagal/deep brain stimulation, phenobarbital, rituximab, cyclophosphamide; post-sedation coma assessment

For expert care or consultations, call: ‪+91-8065906167‬
Explore upcoming medical webinars: https://www.yashodahospitals.com/events

Yashoda Hospitals: Pioneering Healthcare Excellence in Hyderabad

Yashoda Hospitals is among India's leading healthcare providers, renowned for its advanced medical technology and world-class facilities. Guided by visionary leadership, the Yashoda Group of Hospitals has emerged as a center of excellence in healthcare, delivering top-quality medical care to all segments of society. With cutting-edge equipment, a team of expert doctors, and a commitment to compassionate care, Yashoda Hospitals ensures that patients receive the best possible treatment for all their health needs.

For more information on medical treatment, call us at +91- 8065906167

Chat with us in WhatsApp with our experts: https://api.whatsapp.com/send?phone=9...

Stay Informed with the Latest Health News: Yashoda Hospitals brings you the most recent updates in medical advancements and healthcare. From groundbreaking treatments to expert tips on healthy living, we keep you updated on the latest in the healthcare industry.

Always Get an Expert Second Opinion Before deciding on your Treatment/Surgery.

Get a free online second opinion: https://www.yashodahospitals.com/free...

Check Our Health Info Updates: https://www.yashodahospitals.com/blog/

Connect with Us Online:

Website: https://www.yashodahospitals.com/
Like us on Facebook:   / yashodahospitals  
Follow us on Twitter:   / yashodahospital  
Connect on LinkedIn:   / yashodahospitals  
Follow us on Instagram:   / yashoda.hospitals  

#StatusEpilepticus #CriticalCare #NeurocriticalCare #YashodaHospitals #ClinicalExcellence #MedicalEducation #CriticalCareWebinar #TeamBasedCare #CaseBasedLearning